Low Grade Serous Ovarian Cancer
Oncology·MeSH: Pancreatic Neoplasms
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
2 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Low Grade Serous Ovarian Cancer?
BioSniper tracks 2 drugs in development for Low Grade Serous Ovarian Cancer across 1 company.
How many clinical trials target Low Grade Serous Ovarian Cancer?
There are 2 clinical trials targeting Low Grade Serous Ovarian Cancer tracked by BioSniper.
What is the prevalence of Low Grade Serous Ovarian Cancer?
The estimated prevalence of Low Grade Serous Ovarian Cancer is approximately 24.0 per 100,000 population.
Deep-dive into Low Grade Serous Ovarian Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis